DANA BLASKO: Open Payments
NPI 1184786592 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,711 in 61 payments from 13 companies in 2025. Trend: 2023 $788 · 2024 $983 · 2025 $1,711
Food & beverage: $1,711
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $523 |
| GENZYME CORPORATION | 7 | $257 |
| GlaxoSmithKline, LLC. | 11 | $217 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $147 |
| Novartis Pharmaceuticals Corporation | 4 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| Grifols USA, LLC | 3 | $80 |
| CSL Behring | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Genentech USA, Inc. | 2 | $47 |
Products named: DUPIXENT, AIRSUPRA, FASENRA, NUCALA, NEFFY, HYQVIA, TEZSPIRE, Prolastin-C Liquid.
Industry payments across FL — which companies pay providers there.
